Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine

Abstract

Most of the AEFI rates were not greater than the background rates compared with other vaccines, but there was disproportional reporting of syncope and venous thromboembolic events. The significance of these findings must be tempered with the limitations (possible underreporting) of a passive reporting system.